Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
3 studies found for:    ban-2401
Show Display Options
Rank Status Study
1 Completed A Randomized, Double-blind, Placebo-controlled Study to Assess Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Pharmacodynamic Response of Repeated Intravenous Infusions of BAN2401 in Subjects With Mild Cognitive Impairment Due to Alzheimer's Disease and Mild Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: BAN2401 2.5 mg/kg;   Drug: BAN2401 5 mg/kg;   Drug: BAN2401 10 mg/kg;   Drug: Placebo
2 Active, not recruiting A Study to Evaluate Safety, Tolerability, and Efficacy of BAN2401 in Subjects With Early Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: BAN2401 2.5 mg/kg;   Drug: BAN2401 5.0 mg/kg;   Drug: BAN2401 10 mg/kg
3 Completed A Randomized, Double-blind, Placebo-controlled, Combined Single Ascending Dose and Multiple Ascending Dose Study
Condition: Alzheimer's Disease
Interventions: Drug: Active Comparator: A;   Drug: Placebo Comparator B;   Drug: Active Comparator B;   Drug: Placebo Comparator A

Study has passed its completion date and status has not been verified in more than two years.